US 12,064,413 B2
Methods of treating melanoma with S-equol
Rong Li, Washington, DC (US); Bin Yuan, Hefei (CN); and Tyler Curiel, San Antonio, TX (US)
Assigned to The Board of Regents of the University of Texas System, Austin, TX (US)
Filed by The Board of Regents of the University of Texas System, Austin, TX (US)
Filed on Aug. 15, 2022, as Appl. No. 17/819,863.
Application 17/819,863 is a continuation of application No. 16/384,428, filed on Apr. 15, 2019, abandoned.
Claims priority of provisional application 62/728,981, filed on Sep. 10, 2018.
Claims priority of provisional application 62/685,392, filed on Jun. 15, 2018.
Prior Publication US 2022/0387380 A1, Dec. 8, 2022
Int. Cl. A61K 31/353 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01)
CPC A61K 31/353 (2013.01) [A61P 35/00 (2018.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01)] 15 Claims
 
1. A method for treating melanoma, comprising administering a pharmaceutically effective amount of a formulation comprising S-equol in combination with pembrolizumab to a subject in need thereof.